Attoquant Diagnostics is a global company providing high performance analysis of biomarkers supporting research and clinical management of hypertension. We specialize in the analytic challenges of angiotensin quantification for routine applications in clinical settings. Angiotensin-based biomarkers provide deep insights into the dynamic regulation of the Renin-Angiotensin-Aldosterone-System (RAAS). Our latest innovation is the newly launched RAAS Triple-A™ Kit for clinical mass spectrometry. Our vision is to globally improve hypertension control by providing a simple blood test to identify the most frequent underlying causes of uncontrolled hypertension, allowing for a personalized and more effective therapy. Together, let’s bring hypertension management to the next level!